Group items tagged

The National Health Services England (NHSE) is poised to revolutionise diabetes management with the introduction of the 'artificial pancreas', also known as the Hybrid Closed Loop system, to treat type 1 diabetes. This pioneering initiative, endorsed by the National Institute of Health Care and Excellence (NICE), represents a global first in healthcare innovation. With 269,095 individuals grappling with type 1 diabetes in England, the Hybrid Closed Loop system is set to cater to tens of thousands of children and adults across the nation. This cutting-edge device operates by seamlessly monitoring blood glucose levels and autonomously adjusting insulin dosage through a pump, by eliminating the need for regular insulin injections. Furthermore, it holds the promise of averting life-threatening hypoglycaemic and hyperglycaemia episodes, mitigating significant risks associated with the condition. To facilitate the identification of beneficiaries, NHSE has allocated a substantial sum of £2.5 million, ensuring that those who could benefit from this innovative solution receive the necessary support.

Causes of Diabetes,how to treat diabetes,type 2 diabetes,Juvenile Diabetes,Artificial Pancreas,Diabetes Cure,New drugs for diabetes

Apart from changes in your reproductive system, you may also undergo changes in your glands. Your forties tax the immune integrity of your thyroid, which controls your metabolism. Weight gain also causes your pancreas to produce more insulin, which exposes you to risks in terms of heart health, and diabetes development.

The Deadliest Diseases. Insulin is a protein that plays a prominent role in the regulation of sugar level in our bodies. Insulin is produced by the pancreas in the human bodies. When the pancreas doesn't produce insulin then, it becomes quite difficult to balance the sugar level in the blood.

Gastroenterology focuses on the diagnosis and treatment of diseases of the digestive tract esophagus, stomach, small intestine and colon, pancreas and liver

Apollo Hospitals have performed over 3500 transplants, achieving over 90% success rates. We are experts in heart, liver, Kidney, Pancreas, Lung, Intestine & Corneal Transplants. Contact Now

One of the long-standing medical mysteries is the diagnosis of diabetes in majority of patients suffering from high blood pressure. The reason for this had been unknown. But now, an international team of universities have made a breakthrough. The research, published online in 'Circulation Research', involved contributions from collaborating scientists in Brazil, Germany, Lithuania, and Serbia, as well as the UK and New Zealand. The important new discovery has shown that a small protein cell glucagon-like peptide-1 (GLP-1) couples the body's control of blood sugar and blood pressure. Professor Julian Paton, a senior author, and director of Manaaki Manawa, The Centre for Heart Research at the University of Auckland, said: "We've known for a long time that hypertension and diabetes are inextricably linked and have finally discovered the reason, which will now inform new treatment strategies." GLP-1 is released from the wall of the gut after eating and acts to stimulate insulin from the pancreas to control blood sugar levels. This was known but what has now been unearthed is that GLP-1 also stimulates a small sensory organ called the carotid body located in the neck.

In an announcement following Keir Starmer's and Wes Streeting's visit to a hospital in the East Midlands, Labour Party has unveiled a groundbreaking partnership with Virgin Media O2 aimed at ensuring every child with type 1 diabetes can access the latest medical technology to better manage diabetes. With the NHS providing patients with type 1 diabetes the option of an 'artificial pancreas' in the next five years to manage insulin levels and Continuous Glucose Monitors launched nearly 2 years ago to monitor children's glucose levels, the initiative aims to address the financial barrier hindering hundreds of families from benefiting from this breakthrough. Labour's plan to provide every child in need a smartphone, facilitating access to modern glucose monitors, aligns with the centre-leftist party's broader vision to harness technology for healthcare transformation. Announcing the partnership in an interview with ITV News, Keir Starmer, Labour Party Leader, highlighted the lack of equitable access to medical advancement amongst patients as "travesty" and "impact of fourteen years of Conservative chaos has had on the NHS", stating:

Insulin is the powerful anabolic agent that can add weight to you very quickly than the other compounds. The protein, insulin is secreted by pancreas that acts directly on the liver to stimulate glycogen formation from glucose and also to inhibit conversion of non-carbohydrates to glucose.

MANGAFODIPIR is a contrast agent used as a diagnostic tool administered intravenously to enhance contrast in magnetic resonance imaging (MRI) of the liver and pancreas. The contrast agent is present as mangafodipir trisodium marketed under the name TESLASCAN.